Authors:
MOLLA A
VASAVANONDA S
KUMAR G
SHAM HL
JOHNSON M
GRABOWSKI B
DENISSEN JF
KOHLBRENNER W
PLATTNER JJ
LEONARD JM
NORBECK DW
KEMPF DJ
Citation: A. Molla et al., HUMAN SERUM ATTENUATES THE ACTIVITY OF PROTEASE INHIBITORS TOWARD WILD-TYPE AND MUTANT HUMAN-IMMUNODEFICIENCY-VIRUS, Virology (New York, N.Y. Print), 250(2), 1998, pp. 255-262
Authors:
CURTIN ML
DAVIDSEN SK
HEYMAN HR
GARLAND RB
SHEPPARD GS
FLORJANCIC AS
XU LH
CARRERA GM
STEINMAN DH
TRAUTMANN JA
ALBERT DH
MAGOC TJ
TAPANG P
RHEIN DA
CONWAY RG
LUO GJ
DENISSEN JF
MARSH KC
MORGAN DW
SUMMERS JB
Citation: Ml. Curtin et al., DISCOVERY AND EVALUATION OF A SERIES OF 3-ACYLINDOLE IMIDAZOPYRIDINE PLATELET-ACTIVATING-FACTOR ANTAGONISTS, Journal of medicinal chemistry, 41(1), 1998, pp. 74-95
Authors:
LEE RD
GRABOWSKI B
JOHNSON MK
DENISSEN JF
Citation: Rd. Lee et al., DISPOSITION AND EXCRETION OF [H-3] 19-NOR-1-ALPHA,25-DIHYDROXYVITAMIND-2 IN HUMANS, Journal of bone and mineral research, 12, 1997, pp. 402-402
Authors:
DENISSEN JF
GRABOWSKI BA
JOHNSON MK
BUKO AM
KEMPF DJ
THOMAS SB
SURBER BW
Citation: Jf. Denissen et al., METABOLISM AND DISPOSITION OF THE HIV-1 PROTEASE INHIBITOR RITONAVIR (ABT-538) IN RATS, DOGS, AND HUMANS, Drug metabolism and disposition, 25(4), 1997, pp. 489-501
Authors:
KEMPF DJ
MARSH KC
KUMAR G
RODRIGUES AD
DENISSEN JF
MCDONALD E
KUKULKA MJ
HSU A
GRANNEMAN GR
BAROLDI PA
SUN E
PIZZUTI D
PLATTNER JJ
NORBECK DW
LEONARD JM
Citation: Dj. Kempf et al., PHARMACOKINETIC ENHANCEMENT OF INHIBITORS OF THE HUMAN-IMMUNODEFICIENCY-VIRUS PROTEASE BY COADMINISTRATION WITH RITONAVIR, Antimicrobial agents and chemotherapy, 41(3), 1997, pp. 654-660
Authors:
KUMAR GN
RODRIGUES AD
BUKO AM
DENISSEN JF
Citation: Gn. Kumar et al., CYTOCHROME P450-MEDIATED METABOLISM OF THE HIV-1 PROTEASE INHIBITOR RITONAVIR (ABT-538) IN HUMAN LIVER-MICROSOMES (VOL 277, PG 423, 1996), The Journal of pharmacology and experimental therapeutics, 281(3), 1997, pp. 1506-1506
Citation: Gn. Kumar et al., HEPATIC DRUG-METABOLIZING ACTIVITIES IN RATS AFTER 14 DAYS OF ORAL-ADMINISTRATION OF THE HUMAN IMMUNODEFICIENCY VIRUS-TYPE-1 PROTEASE INHIBITOR RITONAVIR (ABT-538), Drug metabolism and disposition, 24(5), 1996, pp. 615-617
Authors:
KUMAR GN
RODRIGUES AD
BUKO AM
DENISSEN JF
Citation: Gn. Kumar et al., CYTOCHROME P450-MEDIATED METABOLISM OF THE HIV-1 PROTEASE INHIBITOR RITONAVIR (ABT-538) IN HUMAN LIVER-MICROSOMES, The Journal of pharmacology and experimental therapeutics, 277(1), 1996, pp. 423-431
Authors:
SHAM HL
ZHAO C
STEWART KD
BETEBENNER DA
LIN SQ
PARK CH
KONG XP
ROSENBROOK W
HERRIN T
MADIGAN D
VASAVANONDA S
LYONS N
MOLLA A
SALDIVAR A
MARSH KC
MCDONALD E
WIDEBURG NE
DENISSEN JF
ROBINS T
KEMPF DJ
PLATTNER JJ
NORBECK DW
Citation: Hl. Sham et al., A NOVEL, PICOMOLAR INHIBITOR OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROTEASES, Journal of medicinal chemistry, 39(2), 1996, pp. 392-397
Authors:
KEMPF DJ
MARSH KC
DENISSEN JF
MCDONALD E
VASAVANONDA S
FLENTGE CA
GREEN BE
FINO L
PARK CH
KONG XP
WIDEBURG NE
SALDIVAR A
RUIZ L
KATI WM
SHAM HL
ROBINS T
STEWART KD
HSU A
PLATTNER JJ
LEONARD JM
NORBECK DW
Citation: Dj. Kempf et al., ABT-538 IS A POTENT INHIBITOR OF HUMAN-IMMUNODEFICIENCY-VIRUS PROTEASE AND HAS HIGH ORAL BIOAVAILABILITY IN HUMANS, Proceedings of the National Academy of Sciences of the United Statesof America, 92(7), 1995, pp. 2484-2488
Authors:
DENISSEN JF
GRABOWSKI BA
JOHNSON MK
BOYD SA
UCHIC JT
STEIN H
CEPA S
HILL P
Citation: Jf. Denissen et al., THE ORALLY-ACTIVE RENIN INHIBITOR A-74273 - IN-VIVO AND IN-VITRO MORPHOLINE RING METABOLISM IN RATS, DOGS, AND HUMANS, Drug metabolism and disposition, 22(6), 1994, pp. 880-888
Authors:
BOYD SA
FUNG AKL
BAKER WR
MANTEI RA
STEIN HH
COHEN J
BARLOW JL
KLINGHOFER V
WESSALE JL
VERBURG KM
POLAKOWSKI JS
ADLER AL
CALZADILLA SV
KOVAR P
YAO ZL
HUTCHINS CW
DENISSEN JF
GRABOWSKI BA
CEPA S
HOFFMAN DJ
GARREN KW
KLEINERT HD
Citation: Sa. Boyd et al., NONPEPTIDE RENIN INHIBITORS WITH GOOD INTRADUODENAL BIOAVAILABILITY AND EFFICACY IN DOG, Journal of medicinal chemistry, 37(19), 1994, pp. 2991-3007